Zobrazeno 1 - 10
of 21
pro vyhledávání: '"P. Steylen"'
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol 2015, Iss default, Pp 57-63 (2015)
Pauline MJ Steylen,1 Frank MMA van der Heijden,1 Witte JG Hoogendijk,2 Willem MA Verhoeven1,21Vincent van Gogh Institute for Psychiatry, Center of Excellence for Neuropsychiatry, Venray, the Netherlands; 2Erasmus University Medical Center, Department
Externí odkaz:
https://doaj.org/article/eb0976810f494127a0f21c9c550e9b02
Autor:
P. Steylen, Willem M.A. Verhoeven, Frank M.M.A. van der Heijden, No A E S Sijben, Hans D.H. Kok
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 17:125-130
The aim of the study was to determine the prevalence of cardiometabolic dysregulations and their somatic treatment regimens in a group of psychiatric patients treated with antipsychotics.In a naturalistic cohort study, baseline cardiometabolic parame
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4e87b2e73a129ad2bfd96b11bd6699
https://doi.org/10.3109/13651501.2013.779000
https://doi.org/10.3109/13651501.2013.779000
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity, 8, 57-63. Dove Medical Press Ltd.
Diabetes, Metabolic Syndrome and Obesity, 8, 57-63. Dove Medical Press Ltd.
Pauline MJ Steylen,1 Frank MMA van der Heijden,1 Witte JG Hoogendijk,2 Willem MA Verhoeven1,21Vincent van Gogh Institute for Psychiatry, Center of Excellence for Neuropsychiatry, Venray, the Netherlands; 2Erasmus University Medical Center, Department
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2715ba94e993359c15bf6ee2f858407b
https://doi.org/10.2147/dmso.s70029
https://doi.org/10.2147/dmso.s70029
Autor:
Hans L.M. Hendrikx, Willem M.A. Verhoeven, Marcel W.P. Hoogenbosch, P. Steylen, Frank M.M.A. van der Heijden, Hans D.H. Kok, Anouk Slaar
Publikováno v:
Schizophrenia Research. 117:517-518
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1064d5c24930adb4a3fb4c5ce494e441
https://doi.org/10.1016/j.schres.2010.02.993
https://doi.org/10.1016/j.schres.2010.02.993
Publikováno v:
European Psychiatry. 28:1
Introduction Treatment with antipsychotic drugs is associated with an increased risk for glucose dysregulation.Hyperglycemia that does not fulfil diagnostic criteria for diabetes mellitus (DM) is known as prediabetes (preDM). PreDM is a strong risk f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c724c91d2bdc1e8a9e82ff65e7871c54
https://doi.org/10.1016/s0924-9338(13)75987-x
https://doi.org/10.1016/s0924-9338(13)75987-x
Publikováno v:
European Psychiatry. 27:1
Introduction Patients with severe mental illnesses (SMI) are at increased risk for cardiovascular disease. Treatment with antipsychotics can induce and worsen cardiometabolic risk factors, like obesity, hypertension, dyslipidemia and hyperglycemia. R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4532871ce373b3e43168bedb7ca1cf09
https://doi.org/10.1016/s0924-9338(12)75070-8
https://doi.org/10.1016/s0924-9338(12)75070-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Psychiatry. 26:1522-1522
IntroductionCardiovascular disease is the most common cause of death in patients with severe mental illness (SMI). Patients are more likely to be overweight and to have hypertension, dyslipidemia, hyperglycemia and diabetes mellitus. Antipsychotic me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2f80c2f3a142b8e52deae2b2325c564
https://doi.org/10.1016/s0924-9338(11)73226-6
https://doi.org/10.1016/s0924-9338(11)73226-6
Publikováno v:
European Psychiatry. 25:1-1
Treatment with psychotropic drugs is frequently associated with obesity, dislipidemia, hyperglycaemia and hypertension, resulting in the development of the metabolic syndrome which in turn is an important risk factor for cardiovascular disease and ty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9f6f7fc3a01781adfaf1f74fdedd7af
https://doi.org/10.1016/s0924-9338(10)70722-7
https://doi.org/10.1016/s0924-9338(10)70722-7
Publikováno v:
European Neuropsychopharmacology. 18:S411
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::439c7bb112db07d6f98b2e82c5fda054
https://doi.org/10.1016/s0924-977x(08)70597-2
https://doi.org/10.1016/s0924-977x(08)70597-2